Innovative Medicine — Supplies expense

Business Segments · Supplies expense

Johnson & Johnson Innovative Medicine — Supplies expense remained flat by 0.0% to $25.00M in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 85.7%, from $175.00M to $25.00M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ4 2022
Last reportedQ4 2024

How to read this metric

An increase relative to revenue may signal rising input costs or manufacturing inefficiencies, while a decrease suggests improved cost management.

Detailed definition

This represents the direct costs associated with raw materials, consumables, and other supplies used in the production a...

Peer comparison

Comparable to cost of goods sold (COGS) components in other pharmaceutical manufacturing segments.

Metric ID: jnj_segment_innovative_medicine_supplies_expense

Historical Data

9 periods
 Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24
Value$800.00M$175.00M$175.00M$175.00M$175.00M$25.00M$25.00M$25.00M$25.00M
QoQ Change-78.1%+0.0%+0.0%+0.0%-85.7%+0.0%+0.0%+0.0%
YoY Change-78.1%-85.7%-85.7%-85.7%-85.7%
Range$25.00M$800.00M
CAGR-82.3%
Avg YoY Growth-84.2%
Median YoY Growth-85.7%
Current Streak3 quarters growth

Frequently Asked Questions

What is Johnson & Johnson's innovative medicine — supplies expense?
Johnson & Johnson (JNJ) reported innovative medicine — supplies expense of $25.00M in Q4 2024.
How has Johnson & Johnson's innovative medicine — supplies expense changed year-over-year?
Johnson & Johnson's innovative medicine — supplies expense decreased by 85.7% year-over-year, from $175.00M to $25.00M.
What does innovative medicine — supplies expense mean?
The direct costs of materials and supplies used to manufacture and deliver pharmaceutical products.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.